258 related articles for article (PubMed ID: 23550609)
1. Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles.
Patel M; Souto EB; Singh KK
Expert Opin Drug Deliv; 2013 Jul; 10(7):889-905. PubMed ID: 23550609
[TBL] [Abstract][Full Text] [Related]
2. Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art.
Gastaldi L; Battaglia L; Peira E; Chirio D; Muntoni E; Solazzi I; Gallarate M; Dosio F
Eur J Pharm Biopharm; 2014 Aug; 87(3):433-44. PubMed ID: 24833004
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases.
Cacciatore I; Ciulla M; Fornasari E; Marinelli L; Di Stefano A
Expert Opin Drug Deliv; 2016 Aug; 13(8):1121-31. PubMed ID: 27073977
[TBL] [Abstract][Full Text] [Related]
4. Colloidal polymeric nanoparticles and brain drug delivery.
Khalil NM; Mainardes RM
Curr Drug Deliv; 2009 Jul; 6(3):261-73. PubMed ID: 19604140
[TBL] [Abstract][Full Text] [Related]
5. Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB.
Nagpal K; Singh SK; Mishra DN
Expert Opin Drug Deliv; 2013 Jul; 10(7):927-55. PubMed ID: 23330786
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-mediated strategies in opening brain barriers for drug brain delivery.
Zhao YZ; Lu CT; Li XK; Cai J
Expert Opin Drug Deliv; 2013 Jul; 10(7):987-1001. PubMed ID: 23550691
[TBL] [Abstract][Full Text] [Related]
7. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.
Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC
Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274
[TBL] [Abstract][Full Text] [Related]
8. Tailoring Lipid and Polymeric Nanoparticles as siRNA Carriers towards the Blood-Brain Barrier - from Targeting to Safe Administration.
Gomes MJ; Fernandes C; Martins S; Borges F; Sarmento B
J Neuroimmune Pharmacol; 2017 Mar; 12(1):107-119. PubMed ID: 27209050
[TBL] [Abstract][Full Text] [Related]
9. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid nanoparticles for targeted brain drug delivery.
Blasi P; Giovagnoli S; Schoubben A; Ricci M; Rossi C
Adv Drug Deliv Rev; 2007 Jul; 59(6):454-77. PubMed ID: 17570559
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.
Fonseca-Santos B; Gremião MP; Chorilli M
Int J Nanomedicine; 2015; 10():4981-5003. PubMed ID: 26345528
[TBL] [Abstract][Full Text] [Related]
12. Chapter 1 - Drug delivery to the brain using colloidal carriers.
Chang J; Jallouli Y; Barras A; Dupont N; Betbeder D
Prog Brain Res; 2009; 180():2-17. PubMed ID: 20302826
[TBL] [Abstract][Full Text] [Related]
13. Liposomes for brain delivery.
Lai F; Fadda AM; Sinico C
Expert Opin Drug Deliv; 2013 Jul; 10(7):1003-22. PubMed ID: 23373728
[TBL] [Abstract][Full Text] [Related]
14. Enhanced permeability of blood-brain barrier and targeting function of brain via borneol-modified chemically solid lipid nanoparticle.
Song H; Wei M; Zhang N; Li H; Tan X; Zhang Y; Zheng W
Int J Nanomedicine; 2018; 13():1869-1879. PubMed ID: 29636606
[TBL] [Abstract][Full Text] [Related]
15. Recent advances on drug delivery nanocarriers for cerebral disorders.
Zhou Z; Sun T; Jiang C
Biomed Mater; 2021 Feb; 16(2):024104. PubMed ID: 33455956
[TBL] [Abstract][Full Text] [Related]
16. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations.
Kathe N; Henriksen B; Chauhan H
Drug Dev Ind Pharm; 2014 Dec; 40(12):1565-75. PubMed ID: 24766553
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticulate devices for brain drug delivery.
Celia C; Cosco D; Paolino D; Fresta M
Med Res Rev; 2011 Sep; 31(5):716-56. PubMed ID: 20162690
[TBL] [Abstract][Full Text] [Related]
19. Nanoscale drug delivery systems and the blood-brain barrier.
Alyautdin R; Khalin I; Nafeeza MI; Haron MH; Kuznetsov D
Int J Nanomedicine; 2014; 9():795-811. PubMed ID: 24550672
[TBL] [Abstract][Full Text] [Related]
20. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
Souto EB; Müller RH
Handb Exp Pharmacol; 2010; (197):115-41. PubMed ID: 20217528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
